Belotero — a Different Filler You May Like 

It may become confusing since there are various options when it comes to hyaluronic acid (HA) fillers. Have you heard of Belotero, which is one of the latest and best in the line-up of fillers? The chances are good that you’ve heard of the fillers Restylane and Juvederm. Much like these two, Belotero is a HA acid filler that is used to fill in fine lines and moderate to severe wrinkles on the face. Its purpose is to add subtle plumpness and facial tissue volume, which gives a person an look that is more youthful and radiant. 

Belotero treatments give natural results with very little recovery time required. The HA acid-based gel is softer than most other products on the market, so it adapts to the contours of the face as it integrates into facial skin more effortlessly. Many patients report seeing immediate results with wrinkle reduction and an appearance that occurs in a more subtle manner and is more natural-looking than other HA fillers. 

The side-effects of Belotero are minimal and typical for the majority of facial fillers, which may include temporary mild bruising and facial redness or swelling for some patients. The main difference between this filler and other HA fillers is that it’s made to treat superficial facial lines and wrinkles that are closer to the surface of the skin. 

Belotero also has lasting power compared to many HA fillers. Results may be seen for up to a year! Most patients notice results for about three to six months following treatment with other HA products. Merz Aesthetics — the developer of Belotero — claims that it lasts a year, on average, compared to six to eight months for Juvederm. 

Belotero may allow doctors to treat superficial lines without the “Tyndall Effect” which sometimes happens when other fillers are injected too superficially. This effect can leave an unwanted bluish hue beneath the skin. 

 Do you desire Belotero treatment? Schedule a consultation now and we will discuss your options! 

 

Leave a Reply

Your email address will not be published.